Guidelines for the management of coagulation disorders in patients with cirrhosis
Copyright © 2023 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. All rights reserved..
Coagulation management in the patient with cirrhosis has undergone a significant transformation since the beginning of this century, with the concept of a rebalancing between procoagulant and anticoagulant factors. The paradigm that patients with cirrhosis have a greater bleeding tendency has changed, as a result of this rebalancing. In addition, it has brought to light the presence of complications related to thrombotic events in this group of patients. These guidelines detail aspects related to pathophysiologic mechanisms that intervene in the maintenance of hemostasis in the patient with cirrhosis, the relevance of portal hypertension, mechanical factors for the development of bleeding, modifications in the hepatic synthesis of coagulation factors, and the changes in the reticuloendothelial system in acute hepatic decompensation and acute-on-chronic liver failure. They address new aspects related to the hemorrhagic complications in patients with cirrhosis, considering the risk for bleeding during diagnostic or therapeutic procedures, as well as the usefulness of different tools for diagnosing coagulation and recommendations on the pharmacologic treatment and blood-product transfusion in the context of hemorrhage. These guidelines also update the knowledge regarding hypercoagulability in the patient with cirrhosis, as well as the efficacy and safety of treatment with the different anticoagulation regimens. Lastly, they provide recommendations on coagulation management in the context of acute-on-chronic liver failure, acute liver decompensation, and specific aspects related to the patient undergoing liver transplantation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:89 |
|---|---|
| Enthalten in: |
Revista de gastroenterologia de Mexico (English) - 89(2024), 1 vom: 10. Jan., Seite 144-162 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aiza-Haddad, I [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bleeding |
|---|
| Anmerkungen: |
Date Completed 22.04.2024 Date Revised 22.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.rgmxen.2023.08.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370893328 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370893328 | ||
| 003 | DE-627 | ||
| 005 | 20240422232425.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240411s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.rgmxen.2023.08.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1383.xml |
| 035 | |a (DE-627)NLM370893328 | ||
| 035 | |a (NLM)38600006 | ||
| 035 | |a (PII)S2255-534X(24)00012-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Aiza-Haddad, I |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Guidelines for the management of coagulation disorders in patients with cirrhosis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.04.2024 | ||
| 500 | |a Date Revised 22.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. All rights reserved. | ||
| 520 | |a Coagulation management in the patient with cirrhosis has undergone a significant transformation since the beginning of this century, with the concept of a rebalancing between procoagulant and anticoagulant factors. The paradigm that patients with cirrhosis have a greater bleeding tendency has changed, as a result of this rebalancing. In addition, it has brought to light the presence of complications related to thrombotic events in this group of patients. These guidelines detail aspects related to pathophysiologic mechanisms that intervene in the maintenance of hemostasis in the patient with cirrhosis, the relevance of portal hypertension, mechanical factors for the development of bleeding, modifications in the hepatic synthesis of coagulation factors, and the changes in the reticuloendothelial system in acute hepatic decompensation and acute-on-chronic liver failure. They address new aspects related to the hemorrhagic complications in patients with cirrhosis, considering the risk for bleeding during diagnostic or therapeutic procedures, as well as the usefulness of different tools for diagnosing coagulation and recommendations on the pharmacologic treatment and blood-product transfusion in the context of hemorrhage. These guidelines also update the knowledge regarding hypercoagulability in the patient with cirrhosis, as well as the efficacy and safety of treatment with the different anticoagulation regimens. Lastly, they provide recommendations on coagulation management in the context of acute-on-chronic liver failure, acute liver decompensation, and specific aspects related to the patient undergoing liver transplantation | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Bleeding | |
| 650 | 4 | |a Chronic liver disease | |
| 650 | 4 | |a Cirrhosis | |
| 650 | 4 | |a Cirrosis | |
| 650 | 4 | |a Enfermedad hepática crónica | |
| 650 | 4 | |a Hemorragia | |
| 650 | 4 | |a Hemostasia | |
| 650 | 4 | |a Hemostasis | |
| 650 | 4 | |a Thrombosis | |
| 650 | 4 | |a Trombosis | |
| 700 | 1 | |a Cisneros-Garza, L E |e verfasserin |4 aut | |
| 700 | 1 | |a Morales-Gutiérrez, O |e verfasserin |4 aut | |
| 700 | 1 | |a Malé-Velázquez, R |e verfasserin |4 aut | |
| 700 | 1 | |a Rizo-Robles, M T |e verfasserin |4 aut | |
| 700 | 1 | |a Alvarado-Reyes, R |e verfasserin |4 aut | |
| 700 | 1 | |a Barrientos-Quintanilla, L A |e verfasserin |4 aut | |
| 700 | 1 | |a Betancourt-Sánchez, F |e verfasserin |4 aut | |
| 700 | 1 | |a Cerda-Reyes, E |e verfasserin |4 aut | |
| 700 | 1 | |a Contreras-Omaña, R |e verfasserin |4 aut | |
| 700 | 1 | |a Dehesa-Violante, M B |e verfasserin |4 aut | |
| 700 | 1 | |a Flores-García, N C |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez-Almaguer, D |e verfasserin |4 aut | |
| 700 | 1 | |a Higuera-de la Tijera, M F |e verfasserin |4 aut | |
| 700 | 1 | |a Lira-Pedrin, M A |e verfasserin |4 aut | |
| 700 | 1 | |a Lira-Vera, J E |e verfasserin |4 aut | |
| 700 | 1 | |a Manzano-Cortés, H |e verfasserin |4 aut | |
| 700 | 1 | |a Meléndez-Mena, D E |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz-Ramírez, M R |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Hernández, J L |e verfasserin |4 aut | |
| 700 | 1 | |a Ramos-Gómez, M V |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez-Ávila, J F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista de gastroenterologia de Mexico (English) |d 2018 |g 89(2024), 1 vom: 10. Jan., Seite 144-162 |w (DE-627)NLM26982152X |x 2255-534X |7 nnns |
| 773 | 1 | 8 | |g volume:89 |g year:2024 |g number:1 |g day:10 |g month:01 |g pages:144-162 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rgmxen.2023.08.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 89 |j 2024 |e 1 |b 10 |c 01 |h 144-162 | ||